Novavax (NVAX) EBT Margin (2010 - 2026)

Novavax's EBT Margin history runs 17 years deep, the most recent figure standing at 6.1% for Q1 2026.

• On a quarterly basis, EBT Margin fell 8408.0% year-over-year to 6.1% in Q1 2026; TTM through Mar 2026 was 16.2%, a 5512.0% decrease from a year earlier, with the FY2025 full-year figure at 39.36%, up 6525.0% from the prior year.
• EBT Margin fell to 6.1% in Q1 2026 per NVAX's latest filing, from 12.17% in the prior quarter.
• Across five years, EBT Margin topped out at 77.98% in Q1 2025 and bottomed at 361.6% in Q1 2023.
• The 5-year median for EBT Margin is 51.63% (2022), against an average of 75.51%.
• Across the five-year window, EBT Margin soared 32177 bps in 2022 and slumped 39088 bps in 2023, its largest moves.
• Year by year, EBT Margin stood at 51.63% in 2022, then decreased by 17 bps to 60.65% in 2023, then sank by 37 bps to 83.32% in 2024, then surged by 115 bps to 12.17% in 2025, then tumbled by 150 bps to 6.1% in 2026.
• Per Business Quant, the three latest NVAX EBT Margin figures stand at 6.1% (Q1 2026), 12.17% (Q4 2025), and 288.22% (Q3 2025).